TD139

Galecto Biotech Books $89 Million in Series C Financing to Develop Fibrosis Candidate
CP Wire
Fri, 10/26/18 - 09:50 am
Galecto Biotech
TD139
idiopathic pulmonary fibrosis
Galecto Biotech Books $89 Million in Series C Financing to Develop Fibrosis Candidate
Fri, 10/26/18 - 09:49 am
Galecto Biotech
TD139
idiopathic pulmonary fibrosis